Nivolumab in the treatment of nonmelanoma skin cancer: multicentre, retrospective analysis of 46 cases
We conducted a multicentre retrospective analysis focusing on objective response rates to evaluate the real-world effectiveness of nivolumab in Japanese patients with advanced nonmelanoma skin cancers, including squamous cell carcinoma, basal cell carcinoma, extramammary Paget disease and eccrine porocarcinoma.
Authors
- Takeo Maekawa (ORCID: https://orcid.org/0000-0001-5865-8487)
- Yasuhiro Fujisawa (ORCID: https://orcid.org/0000-0003-3010-8496)
- Hiroaki Iwata (ORCID: https://orcid.org/0000-0002-8781-2735)
- Hiroshi Kato (ORCID: https://orcid.org/0000-0003-0807-1375)
- Koji Yoshino
- Shusuke Yoshikawa (ORCID: https://orcid.org/0009-0002-6082-4696)
Institutions
- Jichi Medical University (JP)
- Nagoya City University (JP)
- Shizuoka Cancer Center (JP)
- Ehime Medical Center (JP)
- Ehime University Hospital (JP)
- Jichi Medical University Saitama Medical Center (JP)
- Gifu University (JP)
- Japanese Foundation For Cancer Research (JP)
- Ehime University (JP)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1093/bjd/ljaf420
- Primary Topic
- Cancer and Skin Lesions
- Type
- article
- Field-Weighted Citation Impact
- 0.00